| 摘要 |
Human and animal low density lipoprotein receptor ("LDL-R" is used herein to refer to low density lipoprotein receptor; "LDL" is used herein to refer to low density lipoprotein) are administered to provide valuable anti-HIV activity together with anti-Hepatitis viral action. In a preferred aspect, this invention relates to anti-viral and immune regulation activity of the cysteine-rich domain of human low density lipoprotein receptor (LDL-R). As disclosed herein these substances (LDL-R [Human/Animal]) are administered for the treatment of viral infections and as immune regulation agents, and/or these substances are used in the manufacture of a medicament for any such treatment. |
